Léa Saban-Roche

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 164 citations · Full text

Medicine, Infectious Diseases, Oncology +14

Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma

Jean‐Michel Prades, Benjamin Lallemant, R. Garrel et al. · Acta Oto-Laryngologica · 2010 · 79 citations

Medicine, Oncology, Otolaryngology +13

Adjuvant FOLFOX +/− cetuximab in fullRAS andBRAF wildtype stage III colon cancer patients

Ralyath Balogoun, Karine Le Malicot, Josep Tabernero et al. · Annals of Oncology · 2016 · 51 citations · Full text

Medicine, Oncology, Pharmacology +12

Planned neck dissection before combined chemoradiation for pyriform sinus carcinoma

J.-M. Prades, Andréi P. Timoshenko, T Schmitt et al. · Acta Oto-Laryngologica · 2008 · 27 citations

Medicine, Oncology, Otolaryngology +16

Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O ⁶ -Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET)

Thomas Walter, Thierry Lecomte, Julien Hadoux et al. · Journal of Clinical Oncology · 2024 · 19 citations

Medicine, Oncology, Pharmacology +17